Tobacco may speed vax production

As if in answer to HHS secretary Kathleen Sebelius' call last week for faster vaccine production, the Texas Plant-Expressed Vaccine Consortium has unveiled a proof-of-concept initiative for tobacco-based production. Project GreenVax will shoot for 100 million-dose/month capacity in a 145,000-square-foot facility that includes mobile cleanroom pods for specialized purification and lab equipment. Release

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.